[Immunizing property of vaccinia virus inactivated by ultraviolets rays] - PubMed (original) (raw)

. 1954 Oct;148(19-20):1700-2.

[Article in French]

• PMID: 14364998

[Immunizing property of vaccinia virus inactivated by ultraviolets rays]

[Article in French]

Y NAGANO et al. C R Seances Soc Biol Fil. 1954 Oct.

No abstract available

PubMed Disclaimer

Similar articles

• Comparative analysis of tropism between canarypox (ALVAC) and vaccinia viruses reveals a more restricted and preferential tropism of ALVAC for human cells of the monocytic lineage.
  Yu Q, Jones B, Hu N, Chang H, Ahmad S, Liu J, Parrington M, Ostrowski M. Yu Q, et al. Vaccine. 2006 Sep 29;24(40-41):6376-91. doi: 10.1016/j.vaccine.2006.06.011. Epub 2006 Jun 30. Vaccine. 2006. PMID: 16859816
• Experimental inoculation of European red foxes with recombinant vaccinia virus expressing zona pellucida C proteins.
  Reubel GH, Beaton S, Venables D, Pekin J, Wright J, French N, Hardy CM. Reubel GH, et al. Vaccine. 2005 Aug 15;23(35):4417-26. doi: 10.1016/j.vaccine.2005.04.016. Vaccine. 2005. PMID: 15936853
• [Interference of vaccinia virus inactivated by ultraviolet rays with multiplication of homologous virus on a chorio-allantoid membrane].
  MATUMOTO M, SHINKAWA E. MATUMOTO M, et al. C R Seances Soc Biol Fil. 1956 Sep 26;150(5):1062-6. C R Seances Soc Biol Fil. 1956. PMID: 13375031 French. No abstract available.
• Transient and inducible expression of vaccinia/T7 recombinant viruses.
  Mohamed MR, Niles EG. Mohamed MR, et al. Methods Mol Biol. 2004;269:41-50. doi: 10.1385/1-59259-789-0:041. Methods Mol Biol. 2004. PMID: 15114006 Review.
• Construction of recombinant vaccinia viruses using leporipoxvirus-catalyzed recombination and reactivation of orthopoxvirus DNA.
  Yao XD, Evans DH. Yao XD, et al. Methods Mol Biol. 2004;269:51-64. doi: 10.1385/1-59259-789-0:051. Methods Mol Biol. 2004. PMID: 15114007 Review.

Cited by

• Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis.
  Minayoshi Y, Maeda H, Hamasaki K, Nagasaki T, Takano M, Fukuda R, Mizuta Y, Tanaka M, Sasaki Y, Otagiri M, Watanabe H, Maruyama T. Minayoshi Y, et al. Pharmaceuticals (Basel). 2024 Feb 19;17(2):260. doi: 10.3390/ph17020260. Pharmaceuticals (Basel). 2024. PMID: 38399475 Free PMC article.
• Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives.
  Freedman MS, Coyle PK, Hellwig K, Singer B, Wynn D, Weinstock-Guttman B, Markovic-Plese S, Galazka A, Dangond F, Korich J, Reder AT. Freedman MS, et al. Neurol Ther. 2024 Apr;13(2):283-322. doi: 10.1007/s40120-023-00565-7. Epub 2024 Jan 11. Neurol Ther. 2024. PMID: 38206453 Free PMC article. Review.
• Cloning of human Type I interferon cDNAs.
  Nagata S. Nagata S. Proc Jpn Acad Ser B Phys Biol Sci. 2024 Jan 11;100(1):1-14. doi: 10.2183/pjab.100.001. Epub 2023 Nov 30. Proc Jpn Acad Ser B Phys Biol Sci. 2024. PMID: 37648466 Free PMC article.
• Once upon a time, inflammation.
  Cavaillon JM. Cavaillon JM. J Venom Anim Toxins Incl Trop Dis. 2021 Apr 9;27:e20200147. doi: 10.1590/1678-9199-JVATITD-2020-0147. J Venom Anim Toxins Incl Trop Dis. 2021. PMID: 33889184 Free PMC article. Review.
• Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors.
  Onomoto K, Onoguchi K, Yoneyama M. Onomoto K, et al. Cell Mol Immunol. 2021 Mar;18(3):539-555. doi: 10.1038/s41423-020-00602-7. Epub 2021 Jan 18. Cell Mol Immunol. 2021. PMID: 33462384 Free PMC article. Review.

MeSH terms